What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 3 minute read Pharma Industry News AgeneBio enrolls first patient in phase 3 trial for AGB101 in MCI due to Alzheimer’s Disease AgeneBio, a leading biopharmaceutical company specialising in central nervous system (CNS) disorders, has announced the enrolment of the… bypharmanewsdailyJanuary 30, 2019